Anti-U11/U12 Antibodies as a Rare but Important Biomarker in Patients with Systemic Sclerosis: A Narrative Review

Anti-nuclear (ANA) are present in approximately 90% of systemic sclerosis (SSc) patients and are key biomarkers in supporting the diagnosis and determining the prognosis of this disease. In addition to the classification criteria autoantibodies for SSc [i.e., anti-centromere, anti-topoisomerase I (S...

Descripción completa

Detalles Bibliográficos
Autores principales: Fritzler, Marvin J., Bentow, Chelsea, Beretta, Lorenzo, Palterer, Boaz, Perurena-Prieto, Janire, Sanz-Martínez, Maria Teresa, Guillen-Del-Castillo, Alfredo, Marín, Ana, Fonollosa-Pla, Vicent, Callejas-Moraga, Eduardo, Simeón-Aznar, Carmen Pilar, Mahler, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093660/
https://www.ncbi.nlm.nih.gov/pubmed/37046475
http://dx.doi.org/10.3390/diagnostics13071257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093660/
https://www.ncbi.nlm.nih.gov/pubmed/37046475
http://dx.doi.org/10.3390/diagnostics13071257

Ejemplares similares